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Evaluating a Dutch cardiology primary care
plus intervention on the Triple Aim
outcomes: study design of a practice-based
quantitative and qualitative research
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Abstract
Background: In an attempt to deal with the pressures on the health-care system and to guarantee sustainability,
changes are needed. This study focuses on a cardiology primary care plus intervention. Primary care plus (PC+) is a
new health-care delivery model focused on substitution of specialist care in the hospital setting with specialist care
in the primary care setting. The intervention consists of a cardiology PC+ centre in which cardiologists, supported
by other health-care professionals, provide consultations in a primary care setting. The PC+ centre aims to improve
the health of the population and quality of care as experienced by patients, and reduce the number of referrals to
hospital-based outpatient specialist care in order to reduce health-care costs. These aims reflect the Triple Aim
principle. Hence, the objectives of the study are to evaluate the cardiology PC+ centre in terms of the Triple Aim
outcomes and to evaluate the process of the introduction of PC+.
Methods/Design: The study is a practice-based, quantitative study with a longitudinal observational design, and an
additional qualitative study to supplement, interpret and improve the quantitative study. The study population of
the quantitative part will consist of adult patients (≥18 years) with non-acute and low-complexity cardiology-related
health complaints, who will be referred to the cardiology PC+ centre (intervention group) or hospital-based outpatient
cardiology care (control group). All eligible patients will be asked to complete questionnaires at three different time
points consisting of questions about their demographics, health status and experience of care. Additionally, quantitative
data will be collected about health-care utilization and related health-care costs at the PC+ centre and the hospital. The
qualitative part, consisting of semi-structured interviews, focus groups, and observations, is designed to evaluate the
process as well as to amplify, clarify and explain quantitative results.
Conclusions: This study will evaluate a cardiology PC+ centre using quantitative and supplementary qualitative methods.
The findings of both sub-studies will fill a gap in knowledge about the effects of PC+ and in particular whether PC+ is
able to pursue the Triple Aim outcomes.
Trial registration: NTR6629 (Data registered: 25-08-2017) (registered retrospectively).
Keywords: Primary care, Primary care plus, Hospital care, Triple Aim, Substitution, Referral, Cardiology
* Correspondence: t.quanjel@maastrichtuniversity.nl;
m.spreeuwenberg@maastrichtuniversity.nl
1Department of Health Services Research, Care and Public Health Research
Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University,
P.O. Box 616, 6200 MD Maastricht, the Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Quanjel et al. BMC Health Services Research  (2017) 17:628 
DOI 10.1186/s12913-017-2580-x
Background
In an attempt to deal with the pressures on the health-
care system and to guarantee sustainability, changes are
needed [1, 2]. The aging population, along with an in-
crease in chronically ill patients and medical and techno-
logical developments are expected to cause an even
further increase in the health-care expenditures in most
Western countries [3–5]. To guarantee sustainability,
the health-care system should focus on high-value health
care. This implies that initiatives should focus on simul-
taneously pursuing the three aims: improving the health
of the population, improving the quality of care (as expe-
rienced by patients) and reducing the increase of health-
care costs. This is known as the ‘Triple Aim’ principle of
Berwick and colleagues [6, 7].
During the past few years, the Dutch Ministry of Health
has determined strategies to limit the growth of health-
care costs and to increase quality of care [2, 8–12]. A con-
crete action in line with these strategies includes that the
Ministry of Health appointed nine regional initiatives as
‘pioneer sites’. These pioneer sites are able to experiment
with (new) interventions which are focused on the
regional population. They all aim to restructure health
services based on the concept of population management
(PM). Although an unambiguous and widely accepted
definition of PM is lacking, PM initiatives focus on ad-
dressing health needs at all points along the continuum of
health and well-being for a specified population by inte-
grating services across health care, prevention, social care
and welfare [13]. Additionally, these pioneer sites follow
the abovementioned ‘Triple Aim’ principle [6, 7]. A
considerable number of the interventions implemented in
the pioneer site regions are focussing on substitution of
care. Substitution of care can be defined as the continual
regrouping of resources across and within care settings to
exploit the best and least costly solution in the face of
changing needs and demands [14]. All pioneer sites will
be monitored over the coming years.
This paper concerns a practice-based study focused on
a cardiology primary care plus centre which is imple-
mented in one of the appointed pioneer sites. The pion-
eer site, named ‘My Care’, as well as the intervention, is
located in the southern part of the Netherlands [19]. In
the Netherlands, all residents are mandated to purchase
insurance policies, which cover an essential-benefits
package. The majority of the Dutch hospitals are not-
for-profit organizations and virtually all specialists are
hospital-based. GPs act as gatekeepers of the health-care
system and promote consistency and coordination of
individual care [15–17]. All residents are registered with
a GP and have unlimited access to the GP. Hospital and
specialist care is only accessible through GP referral,
with the exception of emergency care. In addition, when
a patient with a particular complaint is referred by a GP
to hospital-based specialist care, the specialist can refer
the patient, for that particular complaint, to another
specialist [16, 17]. It is also important to mention the
influence of the different payment systems for Dutch
health-care professionals. On the one hand, the GP
payment system is a blended model that combines a
capitated fee per enrollee with a relatively small fee for
service payment per visit [15]. This blended GP payment
system does not incentivize GPs to maximize the volume
of care and does not encourage GPs to refer patients to
specialist care. On the other hand, the payment system
of the hospitals is based on a Diagnostic Related Groups
(DRGs)-type system. Specialist fees are integrated into
DRGs. Hospitals, and self-employed specialists, receive a
payment for each DRG. This payment system incentiv-
izes specialists to increase the volume of hospital care by
increasing the number of cases, i.e. DRGs [15, 18].
The practice-based study focuses on a cardiology
Primary Care Plus (PC+) centre. In this pioneer site PC+
implies substitution of specialist care in the hospital
setting with specialist care in the primary care setting
and it is designed for patients with non-acute and low-
complexity related health complaints. Since virtually all
specialists are hospital-based in the Netherlands, PC+ is
a new form of health care. In the cardiology PC+ centre
cardiologists provide consultations in the primary care
setting. During the PC+ consultation the patients receive
a comprehensive screening and afterwards the cardiolo-
gist sends his recommendations for further treatment (if
needed) to the GP. For example, the specialist informs
the GP about whether a referral to hospital care is
needed. Based on the recommendation, the GP discusses
the options for further treatment with the patient. More-
over, within PC+ the GP remains clinically in charge of
the patient. PC+ strengthens the gatekeeping and coord-
inating role of the GP by intensifying the collaboration
and communication between the specialists and the GPs.
The PC+ intervention aims to improve the health of the
population and patients’ experience of care and to
reduce the number of referrals to hospital care (as well
as hospital-based outpatient specialist care) in order to
reduce health-care costs growth. In this study, the PC+
intervention is compared to care-as-usual, both are
described in detail in the methods section. This paper
describes the design of the evaluation of the cardiology
PC+ intervention, combining qualitative and quantitative
methods.
Objectives and underlying premises of PC+
This overall study aims to evaluate the effects of cardi-
ology PC+ centre on the Triple Aim outcomes. The
underlying premises of the researchers on the effects of
the intervention are that the cardiology PC+ centre will
result in an (at least) equivalent health of the population,
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improved quality of care as experienced by patients
and a reduced number of referrals to hospital-based
outpatient cardiology care, and hence reduced health-
care costs.
The underlying premises are grounded on several
hypotheses. Firstly, it is supposed that the health of the
study population (patients with non-acute and low-
complexity cardiology complaints) will be at least the
same, since the patients receive the same diagnostic tests
and the care is provided by health-care professionals
with the same level of expertise. Thus, the cardiology PC
+ centre and hospital-based outpatient cardiology care
will lead to the same health outcomes. After the intro-
duction of PC+, the patients who need more specialized
hospital care are likely to be referred by their GP to the
hospital and the patients who do not need hospital care
will remain in primary care.
Secondly, the aim of the introduction of PC+ is to im-
prove patients’ experience of care. In this study the com-
ponent patients’ experience of care is based upon the six
dimensions of health-care performance of the Institute
of Medicine (IOM), which partially overlaps with the last
premise about health-care costs [19]. It is supposed that
PC+ will improve: 1) the effectiveness of care since PC+
will result in fewer unnecessary referrals to hospital-
based outpatient cardiology care, thus less overuse of
care, 2) the timeliness of care since PC+ will decrease
the waiting time, 3) the patient-centredness of care since
an underlying rationale of PC+ is being respectful and
responsive to individual patient preferences, needs and
values, and 4) the efficiency of care since PC+ will result
in less waste of expensive hospital-based outpatient car-
diology care. Efficiency of care is related to health-care
costs, therefore it will be included in this dimension. In
addition, it is supposed that PC+ has no effect on the
level of 5) safety of care and 6) equity of care and thus it
is supposed that these will remain at the same level.
Finally, it is supposed that the introduction of PC+
will lead to reduced health-care costs by: 1) fewer re-
ferrals to hospital-based outpatient care because of
the introduction of PC+, 2) lower costs in PC+ than
in hospital-based outpatient care, due to lower over-
head costs (i.e. the same cardiology screening will
costs less in PC+), 3) less use of additional hospital-
based services because it is supposed that a signifi-
cant number of the patients referred to PC+ will not
be referred to hospital care afterwards, but will
remain in the primary care setting, and 4) GPs will
gain more knowledge because of the enhanced collab-
oration and communication with the cardiologists.
Hence, in the long term, it is possible that they will
refer fewer patients, to either PC+ or hospital-
outpatient care, for a cardiology screening and instead
treat the patients themselves.
Methods
This clinical observational study will adhere to the
SPIRIT guidelines. The SPIRIT checklist will be used and
it is added as supplementary [see Additional file 1]. The
following paragraphs will describe the intervention ver-
sus care-as-usual, the study design and the methods of
this research.
The pioneer site
The ‘My Care’ region is a geographically demarcated
region, located in the most southern part of the
Netherlands. It consists of 11 municipalities, 277,000
residents, approximately 135 GPs and one hospital. The
region is characterized by a relatively unhealthy popula-
tion with a low socio-economic status (SES) as com-
pared to the overall population of the Netherlands [20].
Moreover, it has the highest percentage of patients with
a chronic disease in the Netherlands, namely 68.5% [20].
This results in a relatively high demand for health care
and thereby high health-care expenditures, especially for
chronic care, diagnostics and medication [21, 22].
The pioneer site ‘My Care’ is a partnership between
the care group called ‘General Practitioners Eastern
South-Limburg’, which is a legal entity of all GPs in the
region (in Dutch: Huisartsen Oostelijk Zuid-Limburg)
[23], the regional hospital Zuyderland Medical Centre,
the patient representative foundation called ‘House for
Care’ (in Dutch: Huis voor de Zorg) and the dominant
health insurance company in the region (named: CZ).
The intervention: the primary care plus centre
The PC+ intervention is a cardiology PC+ centre in
which cardiologists, supported by other health-care
professionals, provide specialist consultations in a pri-
mary care setting. Hospital diagnostic tools are available
including an ultrasound device, an ergometer and an
electrocardiogram (ECG). All GPs in the region participate
in the PC+ intervention and are able to refer non-acute
and low-complexity patients with cardiology-related
complaints to the PC+ centre. Patients who are already
diagnosed with cardiology-related health problems by a
cardiologist are not appropriate for PC+ and (if needed)
they will be treated by the cardiologist in the hospital-care
setting. The consultation at the PC+ centre consists of the
following diagnostic tests: a blood test, an ECG, an echo
and an exercise test. The diagnostic tests are carried out
by multiple health-care professionals, such as nurses,
laboratory technicians and physicians, all specialized in
cardiology. After the tests the patient meets the cardiolo-
gist, who explains the results of the diagnostic tests. The
cardiologist sends a comprehensive description of the
results of the tests, the diagnosis and his recommendation
regarding further treatment (if needed) to the GP. The GP
discusses the cardiologist’s recommendation with the
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patient and based on the principles of shared decision-
making the GP and the patient discuss the options for
further treatment [24]. Moreover, the GP remains clin-
ically in charge of the patient. The further treatment
will depend on the results of the tests and the recom-
mendation of the cardiologist; the three overall
options are: 1) the patient needs no care (i.e. the
patient has no health problems that need further
attention), 2) the patient will remain in the primary
care setting (the patient needs low-complexity care,
e.g. medication) or, 3) the patient will be referred to
secondary care (the patient needs specialist care). The
flow of patients is illustrated in Fig. 1.
Care-as-usual: hospital-based outpatient cardiology care
Hospital-based outpatient cardiology care is considered
care-as-usual. All GPs are allowed to refer non-acute
and low-complexity patients with cardiology-related
complaints to the hospital-based outpatient cardiology
care. These patients receive the same care as within the
PC+ centre, i.e. the same diagnostic tests carried out by
health-care professionals with the same level of expert-
ise. After the tests the patient meets the cardiologist, the
cardiologist explains the results and they discuss further
treatment (if needed). This underlines a significant
difference with the intervention: in the PC+ centre the
cardiologist provides only a recommendation on further
treatment and the GP discusses the options for fur-
ther treatment (instead of the cardiologist), i.e. within
PC+ the GP remains in charge. The flow of patients
is illustrated in Fig. 1.
Study design
The study is a practice-based, quantitative study with a
longitudinal observational design, and an additional
qualitative study to supplement, interpret and improve
the quantitative study. The research study is, at its core,
a quantitative study with qualitative data added to pro-
vide an added value and deeper, wider and fuller answers
to the research questions. These interrelated and reinfor-
cing sub-studies are split up as follows:
1. A quantitative longitudinal observational study
aimed at measuring the effects of PC+.
2. A qualitative study to evaluate the process of the
introduction of PC+ as well as to amplify, clarify and
explain quantitative results.
Sub-study 1: the quantitative study
Aim
The aim of the quantitative part is to measure the effects
of the PC+ intervention on the population’s health, pa-
tients’ experience of care and health-care costs. To
measure the effects the researchers will use the following
sources: patient questionnaires, data from the cardiology
PC+ centre, data from the regional hospital and health
insurance claims data. The data will be collected at four
different time points, namely at baseline, before the pa-
tient has the first consultation with the cardiologist (T0),
a week after the first consultation (T1), 3 months after
the first consultation (T2) and 6 months after the first
consultation (T3). The outcome parameters, including
the dimensions, outcomes, concepts, methods and time
frame, are summarized in Table 1.
Study population
The study population consists of adult patients
(≥18 years) with non-acute and low-complexity
cardiology-related health complaints, registered with a
GP in the region of the pioneer site. Based on the princi-
ples of shared decision-making the GP and the patient
will discuss the options for referral which will be either
the PC+ centre (intervention group) or the hospital-
based outpatient cardiology care (control group). The
decision will be based on expertise and experience of the
GP, the severity of the complaints of the patient and the
preferences of the patient. Less sever, non-acute and
low-complex patients should be referred to PC+. At the
moment, no specific criteria are included for the referral
to PC+. The GP is in charge of referring a patient to the
PC+ centre or the hospital-based outpatient cardiology
care, i.e. the researchers do not have any influence on
the referrals.
Fig. 1 Flowchart: showing the flow of the intervention group and control group
Quanjel et al. BMC Health Services Research  (2017) 17:628 Page 4 of 11
Excluded from participation are patients who are
already diagnosed with cardiology-related health prob-
lems by a cardiologist and patients who have received
balloon angioplasty or bypass surgery in the past
18 months. Furthermore, patients with acute health
problems who require immediate hospital care and/or
patients arriving at the emergency department of the
hospital are excluded from participation.
Recruitment of patients
Regarding the allocation of patients, this is a practice-
based study and therefore the allocation of patients is
not random but based on the decision of the GPs.
The patient enrolment of both the intervention group
and the control group starts when a GP refers a
patient to PC+ or hospital-based outpatient cardiology
care. Furthermore, it will be statistically tested
whether the groups differ in patients’ characteristics
at baseline. In case the there is a difference in
patients’ characteristics at baseline, the propensity
score method (PSM) is used to statistical control for
the differences [25]. In addition, the GP will inform
all patients about the study. Before the consultation
at the PC+ centre or the hospital the patients will
receive an information letter with an informed
consent form. In this letter they are asked if they
would like to participate in the study. All eligible
patients have to give informed consent. The flow of
participants and the time of measurements, i.e. data
collection, are summarized in Fig. 2.
Data collection
Patient questionnaire
All participating patients will be asked to complete ques-
tionnaires at three different time points, namely at base-
line (e.g. before the consultation with the cardiologist
(T0)), within a week after the consultation (T1) and at
three-month follow-up after the consultation (T2). The
baseline questionnaire (T0) consists of questions about
the demographics and health of the patient. Question-
naire 2 (T1) consists of questions about the health of the
patient and about the patient’s experience of care. Ques-
tionnaire 3 (T2) consists only of questions about the
health of the patient. All patients who signed the
informed consent, but of whom the researchers did not
receive the questionnaire yet, will be kindly reminded to
complete the questionnaire. Patients will receive up to
two reminders, one by phone and one by a regular mail.
Moreover, all outcome parameters are explained in one
of the following sections.
Table 1 Overview of the outcome measurements
Dimension Outcome measure Concept Method Data collection time
T0 T1 T2 T3
Population’s health Health status, health-related quality
of life
EQ-5D-5 L Questionnaires X X X
EQ-VAS X X X
SF-12 X X
Experience of care Effectiveness EQ-5D-5 L Questionnaires X X X
Number of referrals Dataa X X X
Timeliness Time between referral of the GP
and appointment at the
PC+ centre/hospital
Questionnaires X X
Patient centred Questions about the experiences
of patients with health care
Questionnaires X
Safety % Hospital admissions Dataa X
% Emergency care visits X
Equity Subgroup analysis, e.g. educational
level and age
Questionnaires X X
Health-care costs Health-care costs: primary care, PC+,
secondary care and diagnostics
Health insurance claims data Dataa X
Efficiency Number of consultations Dataa X
% Hospital admissions X
% Patients referred to hospital after PC+ X
T0 – at baseline: before the consultation
T1 – within a week after the consultation
T2 – 3 months after the consultation (follow-up)
T3 – 6 months after the consultation (follow-up)
aData of the PC+ centre, the hospital and Vektis
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Data from the cardiology PC+ centre
Data registered by the PC+ centre include the following
information about each patient and their consultation:
gender, date of birth, name of referring GP, referral date,
reason(s) for referral (including signs and symptoms of
the patient), consultation date, name of the treating
cardiologist, content of the consultation, recommenda-
tion regarding further diagnostics, treatment or referral,
added value of the consultation, and whether the
patient’s health needs were properly addressed. The
starting point is the date of referral to the PC+ centre
with a follow-up period of 6 months. All data will be
collected by the health-care professionals of the PC+
centre, recorded in one document and exchanged with
the researchers.
Data of the regional hospital
Hospital data include two types of patients: 1) control
group patients and 2) intervention group patients (pa-
tients who have had a consultation at the PC+ centre
and are referred to the hospital afterwards). The col-
lected data are similar to the data of the PC+ centre.
The starting point of the data collection is the date of
referral to the PC+ centre or the hospital-based out-
patient cardiology care with a follow-up period of up to
6 months. In addition to the above-mentioned collected
patient information, the following hospital data will be
provided: the number of consultations, the number of
hospital admissions and the number of emergency care
visits of a patient over a period of 6 months. The data are
extracted from the registration system of the hospital.
Health insurance claims data
This study will only focus on the health-care costs of
patients, which will be measured using the health insur-
ance claims data of the participants, which are available
at Vektis. Vektis is a national information centre for all
the health insurance companies in the Netherlands. The
centre collects all data on the health-care utilization and
health-care costs of all Dutch residents [26]. Health
insurance claims data will be used to examine whether
the health-care costs of an intervention patient (PC+) is
different to the health-care costs of a control patient. To
compare the health-care costs of an intervention patient
with that of a control patient, the health insurance
claims of each patient participating in the intervention
or control group will be used, with a focus on GP care,
PC+ and hospital care. Moreover, it has been decided to
take into account the health-care costs per participant
over a period of 6 months. The starting point is the date
Fig. 2 Flowchart: flow of the participants and measurements
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of referral to the PC+ centre (intervention group) or the
hospital-based outpatient cardiology care (control
group).
Outcome parameters
The outcome parameters are related to the Triple Aim
principle and are focused on (1) population health, (2)
experience of care and (3) health-care costs [6]. All
outcome parameters of the quantitative study, including
the dimension, outcome, concept, method and time of
data collection, are summarized in Table 1. The outcome
parameters, related measures and selected question-
naires are based upon suggested measures by the Insti-
tute of Healthcare Improvement to operationally define
and measure the Triple Aim [27].
Population health
Population health will be measured with three generic
validated questionnaires, namely the EQ-5D-5 L, the
EQ-VAS and the Short Form Health Survey (SF-12).
The EQ-5D-5 L incorporates descriptions and valua-
tions of health status and reflects how patients value
their own health state. The questionnaire comprises the
dimensions mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression [28, 29]. The scores
range from −0.33 to 1 (worst imaginable to best imagin-
able health state), using the Dutch utility tariff [30].
Instead of the EQ-5D-3 L 3-level version, we have
chosen to use the EQ-5D-5 L 5-level, because this
appears to be a valid extension of the 3-level. Several
studies indicate that the measurement properties of the
EQ-5D-5 L are superior to the EQ-5D-3 L in terms of
feasibility, reliability, ceiling effects, discriminatory
power and convergent validity [31–33].
The EQ-VAS (visual analogue scale) is added; this is a
reflection of how patients value their own health state
(range from 0 to 100).
The SF-12 is a subset of the larger SF-36 [34]. The
questionnaire comprises eight health aspects, namely
physical functioning, role limitations because of physical
health problems, bodily pain, general health, vitality
(energy/fatigue), social functioning, role limitations
because of emotional problems, and mental health
(psychological distress and psychological well-being)
[34–37]. The reliability of the SF-12 is high (> 0.80)
[34–37]. In addition, three items from the SF-36 are
added to calculate the Mental Health Inventory score,
comprising the dimensions feeling nervous, feeling
downhearted and blue, and feeling happy [34].
Experience of care
The experience of care will be measured using the
perspective of the patient, i.e. the patient’s interaction
and experience with the health-care system. The
outcome parameters are based upon the six dimensions
of health-care performance of the IOM: safety, effective-
ness, equity, timeliness, patient-centredness and effi-
ciency [19]. As mentioned above, efficiency will be
included in the dimension health-care costs.
Effectiveness of care will be measured with the EQ-
5D-5 L questionnaire and the percentage of referrals to
hospital-based outpatient cardiology care. On the one
hand, effectiveness will be measured using the EQ-5D-
5 L scores, where it is analysed whether the health of the
population is improved after a follow-up of 3 months.
On the other hand, effectiveness will be measured using
the number of referrals to hospital-based outpatient
cardiology care, where it is analysed whether this
number is decreased in the period from 2013 to 2017.
Timeliness of care will be examined by measuring the
waiting time (in days) between the day the patient is
referred by his GP and the day of the first consultation
with the cardiologist.
Patient-centred care will be measured using items
based on the Consumer Quality (CQ) index. The CQ
index is a standardized method for measuring experi-
ences of patients with health care [38]. The question-
naire (T1) includes 30 questions about the experiences
of the patients with health care, with specific regard to
their experiences with the health-care professionals (e.g.
‘Did you feel welcome and at ease?’ and ‘Did the health-
care professionals listen attentively?’).
Safety of care will be measured using data that will be
made available by the hospital concerning: 1) hospital
admissions; 2) emergency care visits.
Equity of care will be examined by performing
subgroup analysis on all outcome measures regarding
educational level (high versus low) and age (lower than
median and higher than median).
Health-care costs
Health-care costs will be measured using health insur-
ance claims data. This study will not cover all related
health-care costs but will only focus on health-care costs
(including patients’ compulsory deductible). Out-of-
pocket payments and indirect costs made from a societal
perspective (e.g. labour market, informal care) will not
be included. The health-care costs per participant is mea-
sured over a period of 6 months after the consultation at
the PC+ centre or the hospital-based outpatient cardi-
ology care. This concerns data regarding health-care costs
on primary care, PC+, hospital care and diagnostics.
Efficiency of care means, according to the IOM, avoid-
ing waste, particularly waste of equipment, supplies, ideas
and energy [19]. With regard to this research, it will be
measured whether the number of consultations of pa-
tients, hospital admissions and referrals will decrease after
the implementation of PC+, which is related to efficient
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use of equipment and health-care professionals and time
of patients. Efficiency of care will be measured using data
from the cardiology PC+ centre, the hospital and Vektis.
The data will consist of the following items: 1) the average
number of consultations at the hospital of a patient over a
period of 6 months; 2) the average number of hospital ad-
missions of a patient over a period of 6 months; and 3) the
number and percentage of patients that are referred to
hospital care after PC+.
Sample size and power calculation
The sample size and power calculation is based on the
referral data of the hospital in 2013 extracted from its
registration system. The data of 2013 show that 12%
(1755 referrals to hospital-based outpatient cardiology
care) of all referrals (14,978 referrals) to the cardiology
department of the hospital are eligible for PC+. These
eligible patients are referred to hospital-based outpatient
cardiology care, which provides, among other health
care, the same health care as the PC+ centre. A decrease
of 50% in the number of referrals to hospital-based out-
patient cardiology care is seen as a relevant difference.
So, the number of referrals eligible for PC+ will decrease
from 1755 (12% of the total referrals to cardiology) refer-
rals to 878 (6% of the total referrals to cardiology).
While assuming a power of 80% and a significance level
of 0.05, 358 patients per group (intervention as well as
control) are required. Taking into account a dropout of
20%, a sample size of 429 patients per group is required,
so this study needs to include 858 patients in total.
To calculate the sample size the following formula was
used to compare proportions:
N ¼ ðZα=2þ ZβÞ
2  p ð1−pÞðr þ 1Þ
ðp0 − p1Þ2 r
With the following meaning of the abbreviations:
Zα/2 = critical value of the normal distribution
at α/2; α = 0.05
1.96
Zβ = critical value of the normal distribution
at β; β is 0.2
0.84
p0 = expected proportion of referrals eligible
for PC+ at baseline
0.12 (12%)
p1 = expected proportion of referrals eligible
for PC+ 1 year after the intervention is implemented
0.06 (6%)
p = (p1+ p0)/2 0.090
r = ratio of patients per group 1
Planned statistical analysis
In general, the continuous outcome measures will be
expressed in means, medians and standard deviations
and the categorical variables in numbers and
percentages.
Descriptive statistics
Demographic data (e.g. gender, age, level of education,
nationality and co-morbidities) will be described for the
total group and for the intervention and control group,
separately. The two groups will be tested on differences
between characteristics, using the t-test for continuous
variables and the chi-square test for categorical variables.
If variables differ between the two groups, with a p-value
≤0.10 they are considered to be potential confounders in
further analysis.
Data analysis
To investigate the effect of PC+ on population health,
patients’ experience of care and health-care costs an
intention to treat analysis will be conducted. The
between-group comparisons will be analysed with multi-
level analysis to account for the dependency of observa-
tions in time. We will apply a two-level linear mixed
model (time, participants) and the level of statistical
significance will be set at 0.05 (two-tailed). Separate
models (random intercept) will be set up for each out-
come measure. The independent variables in each model
are a dummy variable indicating the group (control
group = reference category), three dummy variables for
time (T0 = reference category) and the interaction vari-
able between group and time.
To correct for the possible confounding influence of
baseline characteristics of the patients (e.g. age, gender,
level of education, native country and health-care costs)
and the GP characteristics (e.g. age, gender and practice)
a propensity score will be added into the multilevel
model. The propensity score will be estimated using a
logistic regression model with treatment group (control
or intervention) as dependent variables and baseline var-
iables (patient and GP characteristics) included as inde-
pendent variables. Only baseline variables that are
related to the outcome variable (with a p-value smaller
than 0.10) are included in the propensity score [25].
If normality assumptions are violated, outcome
variables will be log-transformed and if necessary non-
parametric tests will be used.
SPSS version 22 is used to analyse the data.
Procedure for accounting for missing data
The missing values on items in the questionnaires
will be handled according to the scoring algorithms
of the questionnaires. Since it has been shown that
multilevel analysis is a flexible method for handling
missing data for repeated-measures designs, the
missing variables in the follow-up data will not be
imputed [39]. The other missing values, for non-
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repeated measures, will be handled according to
multiple imputation, which means that missing values
will be predicted using existing values from other
variables.
Stopping rules
There are no formal statistical stopping rules. Patients
can withdraw from the study at any time.
Sub-study 2: the qualitative study
Aim
The qualitative study will consist of semi-structured
interviews, focus groups and observations. Besides evalu-
ating the process of the introduction of PC+ (e.g. identi-
fying the barriers and facilitators), the aim of the
qualitative study is to clarify and explain quantitative
results. Therefore, the qualitative study will be based on
an adaptive approach; the ultimate design will depend
on developments during the research and results of the
quantitative study.
Study population
The study population of the qualitative study will
focus on the different stakeholders of the PC+ centre,
namely the manager of the PC+ centre, the head of
the cardiology department of the hospital, GPs,
cardiologists, members of the Steering Committee of
the pioneer site ‘My Care’ and patients. In addition,
interviews and focus groups will be held with
patients. The patients will be recruited purposively in
order to generate a divergent sample of the patient
population. The patient population of the qualitative
study will consist of: patients who had a consultation
at the PC+ centre, patients who had a consultation in
regular hospital-based outpatient care and patients
who had a consultation at the PC+ centre and are
referred to hospital care afterwards.
Data collection
The semi-structured interviews and focus groups will
include the following topics: development, content,
goals and targets of the PC+ intervention, facilitators
and barriers of the introduction of PC+, expected
results, (personal) experiences and, responses and
opinions regarding certain (quantitative) results. The
interviews and focus groups will be held by one inter-
viewer and one observer, and will be audio-recorded.
In addition, the researchers will observe the monthly
meetings of the Steering Committee to collect infor-
mation about the barriers and facilitators of the intro-
duction of PC+. In general, the number of interviews,
focus groups and observations will be based on infor-
mation saturation. Moreover, the qualitative study will
be based on an adaptive approach because the data
collection of the qualitative study is partly based on
the quantitative results.
Data analysis
The recorded interviews will be transcribed verbatim by
the researchers using the transcription instructions of
Poland [40]. The interviews, focus groups and
observations will be analysed using conventional content
analysis methods and if it is assumed to be appropriate,
open colour coding and axial coding methods will be
used [40, 41]. The program NVivo10 will be used as a
supportive tool. All qualitative data will be analysed
independently by at least two researchers. Afterwards,
the researchers will discuss the results. Moreover, the
results will also be validated by performing member
checks, which means that the findings will be discussed
with the particular respondents.
Discussion
Primary care plus (PC+) is a new concept in the Dutch
healthcare system but its support is largely based on
conceptual grounds and evidence about the process of
implementation and the effects is scarce. Therefore, we
will perform a quantitative longitudinal observational
study with an additional reinforcing qualitative study.
The quantitative part focuses on providing insights into
the effects of the PC+ intervention, in terms of the
population health, quality of care as experienced by
patients and health-care costs. Additionally, the qualita-
tive part focuses on evaluating the process of the intro-
duction of PC+ and clarifying and explaining the
quantitative results. The use of both research methods
will result in a broader view for the researchers and it
will add value to the results of this study. For example,
the qualitative data will result in extensive information
about the implementation process of PC+, which will
support the researchers in interpreting the quantitative
results.
This study is a practice-based research. Nowadays,
practice-based research is seen as a viable alternative for
randomized controlled trial design [41, 42]. Practice-
based research has a considerable value because it
ensures connections between science, policy and prac-
tice. A major advantage of practice-based research is
that it results in evidence-based practice, which means
that research findings can be (directly) translated into
policy and practice. Moreover, the external validity of
practice-based research is commonly higher than that of
randomized control trials, since the results are more
generalizable [41, 42].
The study design has some limitations of which the
lack of non-random selection of patients is the most
prominent. Patients will be selected by GPs. The fact
that the selection of the groups is determined by the
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(unobservable) choice of the GP may cause selection
bias. However, selection bias will be limited as the
groups will be equated by the strict prescribed in,- and
exclusion of, the PC+ centre and by using the propensity
score method (PSM) [25]. The PSM reduces the entire
collection of observed baseline variables to a single
score. The estimated propensity score is defined as
the conditional probability of assignment to a particu-
lar group, given a set of observed baseline character-
istics [25, 43]. PSM offers statistical control over
observed baseline differences between patients in a
non-randomized study [25].
The pioneer site ‘My Care’ is engaged in expanding
the PC+ centre with more medical specialities. At
present the centre only offers cardiology care, but in the
near future they will also focus on the following four
specialities: dermatology, minor surgical operation,
internal medicine and ear, nose and throat care.
Consequently, this research will also expand, with
similar studies with regard to the added specialities. This
will also improve this study, since the expanding makes
it possible to examine whether the effectiveness of PC+
is related to the type of speciality. For example, it is
possible that PC+ is effective within the speciality of
dermatology but not within the speciality of surgery.
Additionally, the results of this study will lead to
recommendations for the pioneer site. The pioneer site
can use the recommendations in the design of the
expansion of the PC+ centre with other specialities.
As described in the introduction section, the Dutch
Ministry of Health appointed nine regions as pioneer
sites. All pioneer sites strive to accomplish high-quality
improvements in health care by pursuing the Triple Aim
principle. This intervention is part of one of the pioneer
sites, named ‘My Care’. In the future, it would be inter-
esting to exchange information about the results of PC+
interventions across pioneer sites and also of other PC+
interventions in the Netherlands. For example, it would
be interesting to perform a case study to investigate the
successes and failures of the PC+ interventions within
the Netherlands. These findings can be extremely useful;
as a matter of fact, this would make it possible to mutu-
ally learn from each other. Moreover, most Western
countries attempt to deal with similar pressures on the
health-care system and therewith the increase of the
health-care costs [1, 4, 5]. Additionally, health-care ini-
tiatives focused on the Triple Aim principle are adopted
globally across all health-care systems, for different con-
texts and settings [44]. Hence, our findings might also
be of importance for other countries or regions. If the
PC+ intervention demonstrates progress in the Triple
Aim, this could mean that it is also worth other coun-
tries and regions considering the implementation of PC+
interventions.
Conclusion
In conclusion, this practice-based study, using both
quantitative and qualitative methods, will evaluate the
relatively newly introduced concept of PC+. This study
will focus on a cardiology PC+ centre and the findings
will fill a gap in knowledge about the effects of PC+ and
in particular whether PC+ is able to pursue the Triple
Aim outcomes.
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